Presenilin-mediated modulation of capacitative calcium entry
- PMID: 11055438
- DOI: 10.1016/s0896-6273(00)00066-0
Presenilin-mediated modulation of capacitative calcium entry
Abstract
We studied a novel function of the presenilins (PS1 and PS2) in governing capacitative calcium entry (CCE), a refilling mechanism for depleted intracellular calcium stores. Abrogation of functional PS1, by either knocking out PS1 or expressing inactive PS1, markedly potentiated CCE, suggesting a role for PS1 in the modulation of CCE. In contrast, familial Alzheimer's disease (FAD)-linked mutant PS1 or PS2 significantly attenuated CCE and store depletion-activated currents. While inhibition of CCE selectively increased the amyloidogenic amyloid beta peptide (Abeta42), increased accumulation of the peptide had no effect on CCE. Thus, reduced CCE is most likely an early cellular event leading to increased Abeta42 generation associated with FAD mutant presenilins. Our data indicate that the CCE pathway is a novel therapeutic target for Alzheimer's disease.
Comment in
-
Presenilins, Alzheimer's disease, and capacitative calcium entry.Neuron. 2000 Sep;27(3):411-2. doi: 10.1016/s0896-6273(00)00048-9. Neuron. 2000. PMID: 11055420 No abstract available.
Similar articles
-
Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease.Biochim Biophys Acta. 2009 Jun;1793(6):1050-7. doi: 10.1016/j.bbamcr.2008.11.008. Epub 2008 Dec 6. Biochim Biophys Acta. 2009. PMID: 19111578
-
Presenilins, Alzheimer's disease, and capacitative calcium entry.Neuron. 2000 Sep;27(3):411-2. doi: 10.1016/s0896-6273(00)00048-9. Neuron. 2000. PMID: 11055420 No abstract available.
-
Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein.J Biol Chem. 2003 Jan 24;278(4):2484-9. doi: 10.1074/jbc.M206769200. Epub 2002 Nov 12. J Biol Chem. 2003. PMID: 12431992
-
Identification of the role of presenilins beyond Alzheimer's disease.Pharmacol Res. 2004 Oct;50(4):411-8. doi: 10.1016/j.phrs.2003.12.026. Pharmacol Res. 2004. PMID: 15304238 Review.
-
Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations.Cell Mol Life Sci. 1998 Sep;54(9):902-9. doi: 10.1007/s000180050219. Cell Mol Life Sci. 1998. PMID: 9791532 Free PMC article. Review.
Cited by
-
The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer's disease.Biochim Biophys Acta Mol Cell Res. 2021 May;1868(6):118997. doi: 10.1016/j.bbamcr.2021.118997. Epub 2021 Mar 9. Biochim Biophys Acta Mol Cell Res. 2021. PMID: 33711363 Free PMC article. Review.
-
Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome.Pharmacol Ther. 2007 Feb;113(2):394-409. doi: 10.1016/j.pharmthera.2006.09.005. Epub 2006 Nov 21. Pharmacol Ther. 2007. PMID: 17118456 Free PMC article. Review.
-
Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling.Antioxid Redox Signal. 2011 Apr 1;14(7):1225-35. doi: 10.1089/ars.2010.3421. Epub 2010 Dec 2. Antioxid Redox Signal. 2011. PMID: 20701429 Free PMC article.
-
Store-Operated Calcium Channels.Physiol Rev. 2015 Oct;95(4):1383-436. doi: 10.1152/physrev.00020.2014. Physiol Rev. 2015. PMID: 26400989 Free PMC article. Review.
-
Regulation of Ca2+ signaling with particular focus on mast cells.Crit Rev Immunol. 2009;29(2):155-86. doi: 10.1615/critrevimmunol.v29.i2.40. Crit Rev Immunol. 2009. PMID: 19496745 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical